Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
48.4M
-
Shares change
-
+762K
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
+$14.6M
-
Put/Call ratio
-
54.86
-
Number of buys
-
49
-
Number of sells
-
-32
-
Price
-
$22.67
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2019
114 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q1 2019.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.4M shares
of 49.8M outstanding shares and own 97.28% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (13.4M shares), BAUPOST GROUP LLC/MA (9.31M shares), FMR LLC (8.2M shares), VANGUARD GROUP INC (3.88M shares), BlackRock Inc. (3.72M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.21M shares), STATE STREET CORP (904K shares), NORGES BANK (876K shares), MORGAN STANLEY (687K shares), and NORTHERN TRUST CORP (550K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.